Method for the potentiation of opioid analgesics effects on pain

Details for Australian Patent Application No. 2006260490 (hide)

Owner Lay Line Genomics S.p.A.

Inventors Marinelli, Sara; Cattaneo, Antonio; Ugolini. Gabriele; Pavone, Flaminia

Agent Davies Collison Cave

Pub. Number AU-B-2006260490

PCT Pub. Number WO2006/137106

Priority RM2005A000332 24.06.05 IT

Filing date 23 June 2006

Wipo publication date 28 December 2006

Acceptance publication date 22 September 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 31/485 (2006.01) - Morphinan derivatives, e.g. morphine, codeine

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

3 January 2008 PCT application entered the National Phase

  PCT publication WO2006/137106 Priority application(s): WO2006/137106

22 September 2011 Application Accepted

  Published as AU-B-2006260490

19 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006260503-Comminution plant

2006260484-Molecular complex comprising arbutine, ascorbic acid, oleuropeina or its derivatives thereof and related uses in medical field